Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Surfing the p53 network.

Vogelstein B, Lane D, Levine AJ.

Nature. 2000 Nov 16;408(6810):307-10. No abstract available.

PMID:
11099028
2.

11th Ernst Klenk Lecture. The p53 tumor suppressor gene and product.

Levine AJ.

Biol Chem Hoppe Seyler. 1993 Apr;374(4):227-35. Review. No abstract available.

PMID:
8329141
3.

The p53 tumour suppressor protein.

Hickman ES, Helin K.

Biotechnol Genet Eng Rev. 2000;17:179-211. Review. No abstract available.

PMID:
11255666
4.

DNA damage responses: p53 induction, cell cycle perturbations, and apoptosis.

Canman CE, Chen CY, Lee MH, Kastan MB.

Cold Spring Harb Symp Quant Biol. 1994;59:277-86. Review. No abstract available.

PMID:
7587079
5.

[TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].

Hainaut P.

Bull Cancer. 2000 Jan;87(1):11-8. French. No abstract available.

6.

Death squads enlisted by the tumour suppressor p53.

Michalak E, Villunger A, Erlacher M, Strasser A.

Biochem Biophys Res Commun. 2005 Jun 10;331(3):786-98. Review.

PMID:
15865934
7.

[DNA damage-induced signal pathway of p53 as a tumor suppressor and the gene mutation in human cancer].

Tsuchida N, Gao C, Tsuchida Y, Nakajima T, Nishigaki R.

Tanpakushitsu Kakusan Koso. 2000 Jul;45(10):1742-51. Review. Japanese. No abstract available.

PMID:
10897687
8.

The p53 story: layers of complexity.

Braithwaite AW, Royds JA, Jackson P.

Carcinogenesis. 2005 Jul;26(7):1161-9. Epub 2005 Apr 7. Review.

PMID:
15817608
9.

p53 mutation heterogeneity in cancer.

Soussi T, Lozano G.

Biochem Biophys Res Commun. 2005 Jun 10;331(3):834-42. Review.

PMID:
15865939
10.

Twenty years of p53 research: structural and functional aspects of the p53 protein.

May P, May E.

Oncogene. 1999 Dec 13;18(53):7621-36. Review. No abstract available. Erratum in: Oncogene 2000 Mar 23;19(13):1734.

11.

Living with p53, dying of p53.

Aylon Y, Oren M.

Cell. 2007 Aug 24;130(4):597-600. Review.

12.

p53 regulation of DNA excision repair pathways.

Smith ML, Seo YR.

Mutagenesis. 2002 Mar;17(2):149-56. Review.

PMID:
11880544
13.

DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.

Zhou M, Gu L, Li F, Zhu Y, Woods WG, Findley HW.

J Pharmacol Exp Ther. 2002 Oct;303(1):124-31.

14.

Isolation and characterization of fourteen novel putative and nine known target genes of the p53 family.

Chen X, Liu G, Zhu J, Jiang J, Nozell S, Willis A.

Cancer Biol Ther. 2003 Jan-Feb;2(1):55-62.

PMID:
12673118
15.

p53--a natural cancer killer: structural insights and therapeutic concepts.

Römer L, Klein C, Dehner A, Kessler H, Buchner J.

Angew Chem Int Ed Engl. 2006 Oct 6;45(39):6440-60. Review.

PMID:
16983711
16.

Mutant p53: from guardian to fallen angel?

Deppert W.

Oncogene. 2007 Apr 2;26(15):2142-4. No abstract available.

PMID:
17401422
17.

p53 in health and disease.

Vousden KH, Lane DP.

Nat Rev Mol Cell Biol. 2007 Apr;8(4):275-83. Review.

PMID:
17380161
18.

p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.

Yamaguchi T, Matsuda K, Sagiya Y, Iwadate M, Fujino MA, Nakamura Y, Arakawa H.

Cancer Res. 2001 Nov 15;61(22):8256-62.

20.

The p53 network.

Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR.

J Biol Chem. 1998 Jan 2;273(1):1-4. Review. No abstract available.

Supplemental Content

Support Center